GB150334A - Manufacture of specific vaccines - Google Patents
Manufacture of specific vaccinesInfo
- Publication number
- GB150334A GB150334A GB24351/20A GB2435120A GB150334A GB 150334 A GB150334 A GB 150334A GB 24351/20 A GB24351/20 A GB 24351/20A GB 2435120 A GB2435120 A GB 2435120A GB 150334 A GB150334 A GB 150334A
- Authority
- GB
- United Kingdom
- Prior art keywords
- bacteria
- separated
- added
- addition
- colloid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
150,334. Elektro-Osmose Akt.-Ges., (Graf Schwerin Ges.). Aug. 23, 1919, [Convention date]. Addition to 150,328. Vaccines and immunizing serums.-Specific vaccines prepared by the action of an electric current on suspensions of bacteria as described in the parent Specification are stabilized by the addition of a. protective colloid. The added colloid may be derived from immune blood serum corresponding to the particular bacteria employed so that the resulting vaccines confer passive immunity in addition to the active immunity. The colloid added is preferably a completely soluble proteid such as pseudo-globulin and albumen. In examples, normal blood serum, or immune serum is mixed with bacilli separated from a culture medium or with the whole bouillon culture and placed in the centre compartment of u three-cell electro-osmotic apparatus divided by electrodes and diaphragms, and current is passed for several hours, salt solution being added as required to maintain the conductivity. After the required period the passage of current is continued to eliminate the electrolyte and to cause the separation of euglobulin. The clear solution to be used as a vaccine is separated from the deposit of euglobulin and insoluble bacteria residue in a centrifugal apparatus. In some cases the separated deposit is dissolved in water containing electrolytes and feebly alkaline, and is diluted to form a vaccine to be used alone or mixed with the original clear solution. The bacteria specified are those of swine erysipelas and chicken cholera, and streptococci, pneumococci, and meningococci.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE150328X | 1919-08-23 | ||
DE150334X | 1919-08-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB150334A true GB150334A (en) | 1921-06-30 |
Family
ID=25752455
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB24351/20A Expired GB150334A (en) | 1919-08-23 | 1920-08-21 | Manufacture of specific vaccines |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB150334A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2009493A1 (en) * | 1968-05-28 | 1970-02-06 | Merieux Inst | |
FR2051484A1 (en) * | 1969-05-22 | 1971-04-09 | Pilet Charles | Non agglutinogenic vaccines |
-
1920
- 1920-08-21 GB GB24351/20A patent/GB150334A/en not_active Expired
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2009493A1 (en) * | 1968-05-28 | 1970-02-06 | Merieux Inst | |
FR2051484A1 (en) * | 1969-05-22 | 1971-04-09 | Pilet Charles | Non agglutinogenic vaccines |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GP | Immunity to anthrax: protective antigen present in cell-free culture filtrates. | |
US2961382A (en) | Urokinase-a plasmiogen activator and methods of obtaining the same | |
James | Molecular aspects of biological surfaces | |
Hanahan et al. | Biochemical variability of human erythrocyte membrane preparations, as demonstrated by sodium-potassium-magnesium and calcium adenosinetriphosphatase activities | |
Zotterman et al. | Has water a specific taste? | |
GB150334A (en) | Manufacture of specific vaccines | |
Schechtman | Ontogeny of the blood and related antigens and their significance for the theory of differentiation | |
De Boer et al. | Formation of polynucleate avian erythrocytes by polylysine and phospholipase C | |
Watson et al. | The cilia of Tetrahymena pyriformis: Fractionation of isolated cilia | |
Evans | Haemoglobin electrophoresis on cellulose acetate using whole blood samples. | |
Dreyer | Some new principles in bacterial immunity; their experimental foundation, and their application to the treatment of refractory infections | |
Bisset | Natural antibodies in the blood serum of fresh-water fish | |
Jensen et al. | Submicroscopic particles in normal bovine and human milks: A preliminary morphological survey | |
Olitzki | Electric charge of bacterial antigens | |
McArthur et al. | Antigenic mimicry of eel tissues by a myxosporidian parasite? | |
US3876764A (en) | Vaccines for infectious pustular vulvovaginitis | |
Kazuya et al. | Possible identity between the hepatoma alkaline phosphatase and an isozyme of human amniotic membrane (FL cells) | |
GB505752A (en) | Improved process and apparatus for purifying, separating and concentrating colloidaldispersions | |
Gutfreund | An improved method for the fractionation of protein mixtures by electrophoresis | |
Lynch | Blastocystis species in culture: a preliminary communication | |
Neill | STUDIES ON THE OXIDATION AND REDUCTION OF IMMUNOLOGICAL SUBSTANCES: V. PRODUCTION OF ANTIHEMOTOXIN BY IMMUNIZATION WITH OXIDIZED PNEUMOCOCCUS HEMOTOXIN. | |
Harris | The isoelectric point of silk | |
Sanderson | A note on the bacteriophage with respect to complement fixation tests | |
Bergey | Factors determining the Coagulation of Blood Serum by Bacteria | |
Hindle et al. | A soluble specific substance in spirochaetes |